The end of drug discovery?
by.Hana
In the article “the
end of drug discovery?” author Smitha Mundasad gives information to person who
is engaged in pharmaceutical company. Specifically, author says that the
current situation on industry of medicine is faced with hard crises and he
informs what the future of industry of medicine is. First of all, a medicine
which is invented in the old days discoveries that it is not working well than
ever. Some pharmaceutical companies concern about their profitable medicine
expires. Chas Bountra, who is professor at Oxford University, mentions that
people do not exactly understand about human disease and about the condition of
action of existing drugs. Then, it is hard to find molecule which is using to
new drug. In addition to, there is more competition to publish results because
most of companies study same molecule, carry on wasting resources and perform
clinical trials to patient. There is increasing to develop a newest medicine
with collaboration nowadays. Prof Workman convinces that there is need to
collaborate in early stages of new medicine for diseases, however, the
collaboration will turn into competition at later. in conclusion, he tells
readers to recognize present situation.
This article
very interesting to me because it is related my major in Korea. When I was
freshman in University, a professor always said that Korea’s pharmaceutical
companies are waiting for expiration of blockbuster medicine. The reason is
only one. If original medicine is not expired, generic companies cannot
manufacture a copy of original drug and sell it. As soon as it is expired, Korea companies
ready to publish generic drug. What is the generic drug? It is a copy of the
original drug with the same dosage, safety and quality, but their price has
less expensive. I convince that generic drug can open many more doors to
patient treating their diseases than original drug. I agree that making copy
drug is approved. I wonder whether Americans think positive about generic drug.
United States and Korea cannot be treated as being the same because industry of
medicine in United States is much bigger than Korea. It is really true that
Pfizer annual sale more than including all of pharmaceutical company in Korea
annual sale. Sadly, 2014 looks only a little brighter. What worries me most is
the FTA between United States and Korea. My country is getting into a big
trouble on industry of medicine. That does not have an effect on me immediately,
but it will influence to me next year when I will find a good job.
No comments:
Post a Comment